US Patent Issued to Bioniz Therapeutics on April 14 for "Peptides inhibiting gamma-c-cytokine activity and methods of use" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,757, issued on April 14, was assigned to Bioniz Therapeutics Inc. (La Jolla, Calif.).

"Peptides inhibiting gamma-c-cytokine activity and methods of use" was invented by Nicholas Doerr (Irvine, Calif.), Laith Q. Al-Mawsawi (Sherman Oaks, Calif.) and Nazli Azimi (San Juan Capistrano, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are stable peptide antagonists based on the consensus yc-subunit binding site to inhibit the activity of yc-cytokines. Such peptide antagonists are capable of inhibiting the activity of multiple yc-cytokine family members. The yc-family cytokines are associated with important human diseases, such as l...